63 results
6-K
EX-1.1
ENLV
Enlivex Therapeutics Ltd
29 May 24
Enlivex Therapeutics Closes up to $15 Million Registered Direct Offering
4:20pm
by such Purchaser Party of state or federal securities laws or any conduct by such Purchaser Party which is finally judicially determined to constitute fraud
424B5
ENLV
Enlivex Therapeutics Ltd
29 May 24
Prospectus supplement for primary offering
4:15pm
the sovereignty or security of the State of Israel;
the judgment was obtained by fraud;
the opportunity given to the defendant to bring its
6-K
EX-99.1
0g7cnhbhlb4hnxw
29 Mar 24
Report of Foreign Private Issuer
4:30pm
6-K
EX-99.1
tuove4bpf
31 Mar 23
Report of Foreign Private Issuer
4:30pm
424B5
oz7eqr t7
30 Dec 22
Prospectus supplement for primary offering
4:01pm
F-3
5wse8qlmm1qfw3w
29 Apr 22
Shelf registration (foreign)
8:14am
424B5
h00pvmvz6j60g4
10 Feb 21
Prospectus supplement for primary offering
5:22pm
424B5
wc1cmygb64
9 Feb 21
Prospectus supplement for primary offering
4:56pm